The majority of vertical infections with human immunodeficiency virus type 1 (HIV-1) occur at or near delivery, strongly suggesting a mucosal route of transmission. The frequency and level of intrapartum mucosal exposure to HIV-1 of 22 infants born to infected mothers was investigated. Maternal plasma HIV-1 RNA and CD4 cell count were measured at delivery. Infant oropharyngeal aspirates obtained at birth were examined for HIV-1 RNA by reverse transcription -polymerase chain reaction and qualitative nucleic acid sequence -based amplification. Nine infants (41%) had detectable levels of HIV-1 RNA, 3 of which were quantifiable (mean, 3000 copies/mL). This mucosal exposure to HIV-1 during delivery did not lead to infection of any infant. Cesarian delivery did not reduce mucosal exposure to HIV-1. Mucosal exposure did not correlate with maternal CD4 cell count but did correlate with maternal plasma virus load and was reduced by antiretroviral therapy.
Human immunodeficiency virus type 1 (HIV-1) vertical tion, demonstrating virus transmission via the oral mucosa, although it is important to note the viral infectious dose was transmission may occur in utero, during delivery, or through breast-feeding. In a non -breast-feeding population, transmis-300 times that required for intravenous transmission [7] . This may reflect the physical and immunologic barrier characterission occurs predominately (70%) during delivery. This and other lines of evidence point to the importance of oral mucosal tics of the intact upper gastrointestinal mucosa. More evidence for the requirement of a high infectious dose for mucosal transexposure in HIV-1 vertical transmission [1], the source of virus being maternal blood, cervicovaginal secretions (CVS), or both.
mission comes from studies of HIV-1 -infected discordant twins, in whom the first born is exposed to maternal fluids By using polymerase chain reaction (PCR) -based techniques, HIV RNA can be detected in CVS of 40% -75% of HIV-(CVS, blood) for longer and carries the higher risk of infection, regardless of the mode of delivery [8] . infected women [2] . The duration of infant exposure to the birth canal as a risk factor for HIV transmission has been
To date, a quantitative assessment of intrapartum mucosal exposure of neonates to HIV-1 using sensitive molecular techniques clearly demonstrated in the Women and Infants Study [3] and the New York Study [4] , which showed an almost 2-fold inhas not been done. In the present study, oropharyngeal aspirates (OPA) were collected immediately after birth and assayed for crease in transmission when the fetal membranes were ruptured for ú4 h before delivery. Moreover, the presence of HIV in HIV-1 RNA. The study aimed to examine the frequency and level of intrapartum exposure to HIV-1, as defined by the detection of the gastric aspirates of newborns could be a risk factor for perinatal transmission [5] . Oral infection can also occur postna-HIV-1 RNA in infants' OPA, and the relationship of those factors to maternal stage of disease and mode of delivery. Such investigatally and is well documented in breast-fed neonates [6] .
In rhesus monkeys, oral administration of cell-free simian tions may shed light on the parameters that influence mucosal exposure to HIV-1 during delivery and help in the design and immunodeficiency virus (SIV) to newborn animals led to infecmonitoring of birth canal interventions.
Materials and Methods
ranged from 200 mL to 2 mL. Within 2 h of collection, OPA were NASBA and RT-PCR assays. Extractions and amplifications of the three categories of OPA with each dilution (100, 50, and 25 copies/ equally divided into 100-mL aliquots and centrifuged at 12,000 g for 5 min at room temperature. Electron microscopy studies have 100 mL) were carried out in triplicate to determine whether the quality of the OPA affects the sensitivity of the assays. shown that HIV-1 particles form aggregates in adult human salivary mucins [9] . OPA were therefore centrifuged after collection, Statistical analysis. Medians were compared by Mann-Whitney U test, and the proportions of patients in distinct groups were and HIV-1 RNA was assessed in both supernatants and pellets. The supernatants and pellets were either stored at 070ЊC until compared using Fisher's exact test. used or immediately processed for RNA extraction using the nucleic acid sequence-based amplification (NASBA; Organon Tek- in 100% and 55% of cases, respectively. In RT-PCR of samples Extracted RNA (5 mL) was subjected to cDNA synthesis for 1 spiked with 100, 50, and 25 copies, RNA was detected in h at 42ЊC in a reaction volume of 20 mL containing 6 mM outer 100%, 78%, and 22%, respectively, regardless of the nature or anti-sense primer, 11 first-strand buffer (Gibco-BRL, Gaithersburg, appearance of the OPA. were negative by RT-PCR, perhaps due to its lower sensitivity. each dNTP at 30 mM, 10 pmol of each outer primer, and 2 U of
Results
Four of the 22 pellets tested were inhibitory to the NASBA Maternal and obstetric factors. The median maternal virus load measurement in the CVS of these women. However, in our study, 7 of 9 infants with HIV-positive OPA were delivplasma virus load at delivery was significantly higher for the group in whom infant OPA was HIV RNA -positive (4.0 log 10 ered by elective cesarian section, which suggests that in those cases, the source of virus was maternal blood. RNA copies/mL) than for the group in whom neonate OPA was HIV RNA -negative (3.1 log 10 RNA copies/mL) (MannOur pilot study shows that virus can be found in ú40% of neonates' OPA obtained at delivery. Intrapartum exposure to Whitney U test, P õ .05). Antiretroviral therapy significantly reduced the incidence of mucosal exposure; 4 of the 9 mothers a detectable level correlated with maternal plasma HIV burden, and perinatal antiretroviral therapy was significantly associated of infants with positive OPA had received antiretrovirals, compared with 12 of 13 mothers whose infants had negative OPA with a reduced incidence of oral exposure to HIV-1. For countries where antiretroviral therapy is not affordable, development (Fisher's exact test, P Å .023). There was no correlation between OPA positivity and mode of delivery or median maternal of birth canal preventative interventions is important. Biggar et al. [13] undertook such a study in Malawi, using vaginal CD4 cell count at delivery. Table 1 summarizes the relationships between an HIV-1 -positive OPA and maternal factors.
cleansing with chlorhexidine solution every 4 h during labor. Overall, there was no difference in the rate of HIV transmission between the intervention and control groups (transmission rate Discussion with chlorhexidine, 27%; without chlorhexidine, 28%). However, when the fetal membranes were ruptured for ú4 h, vagiThe presence in 22 neonates of HIV-1 RNA in OPA obtained nal cleansing appeared to have an effect (transmission rate with immediately at delivery was used as a marker of mucosal expochlorhexidine, 25%; without chlorhexidine, 39%; P Å .02). sure to HIV-1 during delivery. We detected HIV-1 RNA in the Although further studies will be necessary to correlate the de-OPA of 41% (n Å 9) of infants born to HIV-1 -infected women.
tection of HIV-1 RNA in OPA with a higher risk of transmisThe virus load was low, with 6 of the 9 having levels below sion, our technique could be used to assess the effect of birth the threshold of the NASBA quantitative assay (1300 HIV canal interventions designed to prevent perinatal transmission. RNA copies/mL) and a mean load of 3000 HIV RNA copies/ mL in the remaining 3. This level of exposure did not result in infection of the infants. This observation is in accordance 
